Lynn Schachinger, DO
Gastroenterology · Jackson, MINPI 1851420947
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $320 of the $374 with a category attached, or 85.7%. 7 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 39.9% of the total. Reporting peaked in 2019 at $263 and has fallen 93.6% since, to $17 in 2022. That places this record below the midpoint for gastroenterology clinicians in MI, where the typical reported total is $1,620.
Across 21 payments — averaging $17.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$149
- Shionogi Inc$74
- Braintree Laboratories, Inc.$67
- Johnson & Johnson$40
- Bristol Myers Squibb$17
- GSK$15
- plus $11 from 1 others
What the payments were for
- Food & beverage$32086%
- Gifts$5314%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $149 |
| Shionogi Inc | 5 | $74 |
| Braintree Laboratories, Inc. | 2 | $67 |
| Johnson & Johnson | 3 | $40 |
| Bristol Myers Squibb | 1 | $17 |
| GSK | 1 | $15 |
| Shire North American Group Inc | 1 | $11 |
How this compares
$374 in reported general payments places this provider in the 30th percentile of 497 gastroenterology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 20 | $9,342 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 137 | $4,989 |
| Omeprazole | 99 | $983 |
| Pantoprazole Sodium | 33 | $658 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Jackson
- Kimberly BrownDetroit$733K
- Dilip MoonkaDetroit$611K
- Philip SchoenfeldAnn Arbor$539K
- Michelle Muza-MoonsAnn Arbor$481K
- Partha NandiTroy$377K
- Bradford WhitmerSaint Clair Shores$206K
- Mohammed BarawiSt Clair Shores$193K
- Stuart GordonDetroit$178K
- Mohamad AlsibaeRoyal Oak$127K
- Allison SchulmanAnn Arbor$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.